Androgen Receptor CpG Island Methylation Status in Human Leukemia Cancer Cells

REFERENCES

• Evans R. M. The steroid and thyroid hormone receptor superfamily. Science 1988; 240(4854)889–894
   PubMed Web of Science ®Google Scholar
• Eliassen A. H., Missmer S. A., Tworoger S. S., Spiegelman D., Barbieri R. L., Dowsett M., Hankinson S. E. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006; 98(19)1406–1415
   PubMed Web of Science ®Google Scholar
• Campan M., Weisenberger D. J., Laird P. W. DNA methylation profiles of female steroid hormone-driven human malignancies. Curr Top Microbiol Immunol. 2006; 310: 141–178
   PubMedGoogle Scholar
• Uchikawa J., Shiozawa T., Shih H. C., Miyamoto T., Feng Y. Z., Kashima H., Oka K., Konishi I. Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression. Cancer 2003; 98(10)2207–2213
   PubMed Web of Science ®Google Scholar
• Rau K. M., Kang H. Y., Cha T. L., Miller S. A., Hung M. C. The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers. Endocr Relat Cancer 2005; 12(3)511–532
   PubMed Web of Science ®Google Scholar
• Melki J. R., Clark S. J. DNA methylation changes in leukaemia. Semin Cancer Biol 2002; 12(5)347–357
   PubMed Web of Science ®Google Scholar
• Melki J. R., Vincent P. C., Clark S. J. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999; 59(15)3730–3740
   PubMed Web of Science ®Google Scholar
• Rush L. J., Raval A., Funchain P., Johnson A. J., Smith L., Lucas D. M., Bembea M., Liu T. H., Heerema N. A., Rassenti L., Liyanarachchi S., Davuluri R., et al. Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets. Cancer Res 2004; 64(7)2424–2433
   PubMed Web of Science ®Google Scholar
• Rush L. J., Plass C. Alterations of DNA methylation in hematologic malignancies. Cancer Lett 2002; 185(1)1–12
   PubMed Web of Science ®Google Scholar
• Cross S. H., Bird A. P. CpG islands and genes. Curr Opin Genet Dev 1995; 5(3)309–314
   PubMed Web of Science ®Google Scholar
• Bird A. P. CpG-rich islands and the function of DNA methylation. Nature 1986; 321(6067)209–213
   PubMed Web of Science ®Google Scholar
• Gardiner-Garden M., Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987; 196(2)261–282
   PubMed Web of Science ®Google Scholar
• Moriguchi K., Yamashita S., Tsujino Y., Tatematsu M., Ushijima T. Larger numbers of silenced genes in cancer cell lines with increased de novo methylation of scattered CpG sites. Cancer Lett 2007; 249(2)178–187
   PubMed Web of Science ®Google Scholar
• Baylin S. B., Chen W. Y. Aberrant gene silencing in tumor progression: implications for control of cancer. Cold Spring Harb Symp Quant Biol 2005; 70: 427–433
   PubMedGoogle Scholar
• Czekierdowski A., Czekierdowska S., Wielgos M., Smolen A., Kaminski P., Kotarski J. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer. Neuro Endocrinol Lett 2006; 27(3)381–386
   PubMed Web of Science ®Google Scholar
• Gebhard C., Schwarzfischer L., Pham T. H., Schilling E., Klug M., Andreesen R., Rehli M. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia. Cancer Res 2006; 66(12)6118–6128
   PubMed Web of Science ®Google Scholar
• Jair K. W., Bachman K. E., Suzuki H., Ting A. H., Rhee I., Yen R. W., Baylin S. B., Schuebel K. E. De novo CpG island methylation in human cancer cells. Cancer Res 2006; 66(2)682–692
   PubMed Web of Science ®Google Scholar
• Agirre X., Roman-Gomez J., Vazquez I., Jimenez-Velasco A., Garate L., Montiel-Duarte C., Artieda P., Cordeu L., Lahortiga I., Calasanz M. J., Heiniger A., Torres A., et al. Abnormal methylation of the common PARK2 and PACRG promoter is associated with downregulation of gene expression in acute lymphoblastic leukemia and chronic myeloid leukemia. Int J Cancer 2006; 118(8)1945–1953
   PubMed Web of Science ®Google Scholar
• Liu Z. J., Lu X., Zhang Y., Zhong S., Gu S. Z., Zhang X. B., Yang X., Xin H. M. Downregulated mRNA expression of ASPP and the hypermethylation of the 5′-untranslated region in cancer cell lines retaining wild-type p53. FEBS Lett 2005; 579(7)1587–1590
   PubMed Web of Science ®Google Scholar
• Issa J. P., Baylin S. B., Herman J. G. DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia 1997; 11(Suppl 1)S7–11
   PubMed Web of Science ®Google Scholar
• Issa J. P., Zehnbauer B. A., Civin C. I., Collector M. I., Sharkis S. J., Davidson N. E., Kaufmann S. H., Baylin S. B. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 1996; 56(5)973–977
   PubMed Web of Science ®Google Scholar
• Liu Z. J., Zhang X. B., Zhang Y., Yang X. Progesterone receptor gene inactivation and CpG island hypermethylation in human leukemia cancer cells. FEBS Lett 2004; 567(2-3)327–332
   PubMed Web of Science ®Google Scholar
• Lubahn D. B., Joseph D. R., Sullivan P. M., Willard H. F., French F. S., Wilson E. M. Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 1988; 240(4850)327–330
   PubMed Web of Science ®Google Scholar
• Kuiper G. G., Faber P. W., van Rooij H. C., van der Korput J. A., Ris-Stalpers C., Klaassen P., Trapman J., Brinkmann A. O. Structural organization of the human androgen receptor gene. J Mol Endocrinol 1989; 2(3)R1–4
   PubMed Web of Science ®Google Scholar
• Felgner J., Heidorn K., Korbacher D., Frahm S. O., Parwaresch R. Cell lineage specificity in G-CSF receptor gene methylation. Leukemia 1999; 13(4)530–534
   PubMed Web of Science ®Google Scholar
• Available from: http://www.urogene.org/methprimer/index1.html MethPrimer
   Google Scholar
• Li L. C., Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18(11)1427–1431
   PubMed Web of Science ®Google Scholar
• Gelmann E. P. Molecular biology of the androgen receptor. J Clin Oncol 2002; 20(13)3001–3015
   PubMed Web of Science ®Google Scholar
• Huang H., Tindall D. J. The role of the androgen receptor in prostate cancer. Crit Rev Eukaryot Gene Expr 2002; 12(3)193–207
   PubMed Web of Science ®Google Scholar
• Chlenski A., Nakashiro K., Ketels K. V., Korovaitseva G. I., Oyasu R. Androgen receptor expression in androgen-independent prostate cancer cell lines. Prostate 2001; 47(1)66–75
   PubMed Web of Science ®Google Scholar
• Jarrard D. F., Kinoshita H., Shi Y., Sandefur C., Hoff D., Meisner L. F., Chang C., Herman J. G., Isaacs W B, Nassif N. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. Cancer Res 1998; 58(23)5310–5314
   PubMed Web of Science ®Google Scholar
• Sasaki M., Tanaka Y., Perinchery G., Dharia A., Kotcherguina I., Fujimoto S., Dahiya R. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J Natl Cancer Inst 2002; 94(5)384–390
   PubMed Web of Science ®Google Scholar
• Sasaki M., Oh B. R., Dharia A., Fujimoto S., Dahiya R. Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer. Mol Carcinog 2000; 29(2)59–66
   PubMed Web of Science ®Google Scholar
• Shim H. S., Jung W. H., Kim H., Park K., Cho N. H. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions. APMIS 2006; 114(5)352–358
   PubMed Web of Science ®Google Scholar
• Catalano M. G., Pfeffer U., Raineri M., Ferro P., Curto A., Capuzzi P., Corno F., Berta L., Fortunati N. Altered expression of androgen-receptor isoforms in human colon-cancer tissues. Int J Cancer 2000; 86(3)325–330
   PubMed Web of Science ®Google Scholar
• Mantalaris A., Panoskaltsis N., Sakai Y., Bourne P., Chang C., Messing E. M., Wu J. H. Localization of androgen receptor expression in human bone marrow. J Pathol 2001; 193(3)361–366
   PubMed Web of Science ®Google Scholar
• McDonald H. L., Gascoyne R. D., Horsman D. C.J. Involvement of the X chromosome in non-Hodgkin lymphoma. Genes Chromosomes Cancer 2000; 28(3)246–57
   PubMed Web of Science ®Google Scholar
• Yang H., Chen C. M., Yan P., Huang T. H., Shi H., Burger M., Nimmrich I., Maier S., Berlin K., Caldwell C. W. The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomas. Clin Cancer Res 2003; 9(11)4034–4042
   PubMed Web of Science ®Google Scholar
• Jones P. A., Takai D. The role of DNA methylation in mammalian epigenetics. Science 2001; 293(5532)1068–1070
   PubMed Web of Science ®Google Scholar
• Jones P. A. The DNA methylation paradox. Trends Genet 1999; 15(1)34–37
   PubMed Web of Science ®Google Scholar
• Nass S. J., Herman J. G., Gabrielson E., Iversen P. W., Parl F. F., Davidson N. E., Graff J. R. Aberrant methylation of the estrogen receptor and E-cadherin 5′ CpG islands increases with malignant progression in human breast cancer. Cancer Res 2000; 60(16)4346–4348
   PubMed Web of Science ®Google Scholar
• Kang J. H., Kim S. J., Noh D. Y., Park I. A., Choe K. J., Yoo O. J., Kang H. S. Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. Lab Invest 2001; 81(4)573–579
   PubMed Web of Science ®Google Scholar
• Sharma G., Mirza S., Prasad C. P., Srivastava A., Gupta S. D., Ralhan R. Promoter hypermethylation of p16(INK4A), p14(ARF), CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci 2007; 80(20)1873–1881
   PubMed Web of Science ®Google Scholar
• Reibenwein J., Pils D., Horak P., Tomicek B., Goldner G., Worel N., Elandt K., Krainer M. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance. Prostate 2007; 67(4)427–432
   PubMed Web of Science ®Google Scholar
• Kawakami K., Ruszkiewicz A., Bennett G., Moore J., Grieu F., Watanabe G., Iacopetta B. DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer 2006; 94(4)593–598
   PubMed Web of Science ®Google Scholar
• Park J., Brena R. M., Gruidl M., Zhou J., Huang T., Plass C., Tockman M. S. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis. Cancer Biomark 2005; 1(2-3)193–200
   PubMedGoogle Scholar
• Baylin S. B., Herman J. G., Graff J. R., Vertino P. M., Issa J. P. Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141–196
   PubMed Web of Science ®Google Scholar
• Palmisano W. A., Divine K. K., Saccomanno G., Gilliland F. D., Baylin S. B., Herman J. G., Belinsky S. A. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000; 60(21)5954–5958
   PubMed Web of Science ®Google Scholar
• Liu Z. J., Maekawa M., Horii T., Morita M. The multiple promoter methylation profile of PR gene and ERalpha gene in tumor cell lines. Life Sci 2003; 73(15)1963–1972
   PubMed Web of Science ®Google Scholar
• Yates D. R., Rehman I., Abbod M. F., Meuth M., Cross S. S., Linkens D. A., Hamdy F. C., Catto J. W. Promoter hypermethylation identifies progression risk in bladder cancer. Clin Cancer Res 2007; 13(7)2046–2053
   PubMed Web of Science ®Google Scholar
• Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8(4)286–298
   PubMed Web of Science ®Google Scholar
• Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H., Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J 1990; 9(5)1603–1614
   PubMed Web of Science ®Google Scholar
• Ottaviano Y L, Issa J P, Parl F F, Smith H S, Baylin S B, Davidson N E. Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. Cancer Res. 1994; 54(10)2552–2555
   PubMed Web of Science ®Google Scholar
• Lapidus R. G., Ferguson A. T., Ottaviano Y. L., Parl F. F., Smith H. S., Weitzman S. A., Baylin S. B., Issa J. P., Davidson N. E. Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res 1996; 2(5)805–810
   PubMed Web of Science ®Google Scholar